rood blauwe elepsis logo Belegger.nl

Isotis Terug naar discussie overzicht

zou de uitslag v/d stemming al gekend zijn?

3 Posts
| Omlaag ↓
  1. had ik maar 22 oktober 2007 20:20
    Zou Dhr. Wolters de uitslag van de stemming al kennen?
    Vermits hij de verdelers van IsoTis producten al inviteert op een woensdag a.s. te houden cocktail receptie, donderdag is er zelfs al een ontbijtsessie voorzien.

    Voorts heeft de nieuwe Integra/IsoTis combinatie ambitieuze plannen, zo valt in dezelfde sec filling van 19/10:
    ccbn.10kwizard.com/cgi/convert/rtf/IS...

    Dear Distributor Principals,............
    We are confident that the combination of IsoTis and Integra will be a very exciting proposition for our distributor organizationsas we anticipate offering you several new products in 2008.

    I look forward to seeing you at NASS in Austin next week, at the IsoTis cocktail reception on Wednesday and at the IsoTisdistributor breakfast on Thursday, where we will also be happy to introduce you to Integra’s senior management.

    As always if you have any questions, please feel free to contact me personally.

    Best Regards,

    Pieter Wolters

    Dear IsoTis Distributor Principals,
    This is to keep you posted on upcoming activities related to the pending merger of Integra LifeSciences Holdings Corporationand IsoTis, Inc. We are working hard to close the transaction and plan the integration of the respective businesses such that thecombination of the two will be of significantly higher value to our distributors and
    our customers.

    We remain enthusiastically committed to the current distributor organization and are well along in the process of planning theorganization of our combined entities to support this effort going forward. Some of the plans currently in process include, but arenot limited to, the following:

    1. Launch a Collagen Ceramic Matrix product through the dealer network in both compression resistant strip form and in aputty form.

    2. Launch next generation DBM products in 2008.

    3. Conduct dealer training for new product launches in Q1 2008 (We will invite the distributors’ top orthobiologicssales representatives to this training).

    4. Create processes for dealer feedback on the launch of new products as well as for support of existing business.

    More information on these programs will be forthcoming.

    In an effort to keep you informed with each step we make until the end of the year and to reiterate our commitment to thedistribution team we already have in place, we will:

    1. Host a distributor breakfast at NASS where executive management
    will discuss long term opportunities.
    2. Send frequent communications to update you on any relevant
    activity.

    Our goal is to have as smooth as a transition as possible and to provide you the most successful and rewarding selling experiencepossible. We encourage you to contact either of us with any questions or concerns via email or phone.

    We look forward to continuing to build on your successes in selling the IsoTis products.

    Hoping to see you in Austin,

    Brian Larkin,
    brian.larkin@integra-ls.com
    President of Integra NeuroSciences
    Jim Abraham
    jim.abraham@isotis.com

    Vice President of Sales, IsoTis Orthobiologics

    Over galgenhumor gesproken!

    Groet,

    hadikmaar
  2. [verwijderd] 23 oktober 2007 08:58
    quote:

    had ik maar schreef:

    Zou Dhr. Wolters de uitslag van de stemming al kennen?
    Vermits hij de verdelers van IsoTis producten al inviteert op een woensdag a.s. te houden cocktail receptie, donderdag is er zelfs al een ontbijtsessie voorzien.

    Voorts heeft de nieuwe Integra/IsoTis combinatie ambitieuze plannen, zo valt in dezelfde sec filling van 19/10:
    ccbn.10kwizard.com/cgi/convert/rtf/IS...

    Dear Distributor Principals,............
    We are confident that the combination of IsoTis and Integra will be a very exciting proposition for our distributor organizationsas we anticipate offering you several new products in 2008.

    I look forward to seeing you at NASS in Austin next week, at the IsoTis cocktail reception on Wednesday and at the IsoTisdistributor breakfast on Thursday, where we will also be happy to introduce you to Integra’s senior management.

    As always if you have any questions, please feel free to contact me personally.

    Best Regards,

    Pieter Wolters

    Dear IsoTis Distributor Principals,
    This is to keep you posted on upcoming activities related to the pending merger of Integra LifeSciences Holdings Corporationand IsoTis, Inc. We are working hard to close the transaction and plan the integration of the respective businesses such that thecombination of the two will be of significantly higher value to our distributors and
    our customers.

    We remain enthusiastically committed to the current distributor organization and are well along in the process of planning theorganization of our combined entities to support this effort going forward. Some of the plans currently in process include, but arenot limited to, the following:

    1. Launch a Collagen Ceramic Matrix product through the dealer network in both compression resistant strip form and in aputty form.

    2. Launch next generation DBM products in 2008.

    3. Conduct dealer training for new product launches in Q1 2008 (We will invite the distributors’ top orthobiologicssales representatives to this training).

    4. Create processes for dealer feedback on the launch of new products as well as for support of existing business.

    More information on these programs will be forthcoming.

    In an effort to keep you informed with each step we make until the end of the year and to reiterate our commitment to thedistribution team we already have in place, we will:

    1. Host a distributor breakfast at NASS where executive management
    will discuss long term opportunities.
    2. Send frequent communications to update you on any relevant
    activity.

    Our goal is to have as smooth as a transition as possible and to provide you the most successful and rewarding selling experiencepossible. We encourage you to contact either of us with any questions or concerns via email or phone.

    We look forward to continuing to build on your successes in selling the IsoTis products.

    Hoping to see you in Austin,

    Brian Larkin,
    brian.larkin@integra-ls.com
    President of Integra NeuroSciences
    Jim Abraham
    jim.abraham@isotis.com

    Vice President of Sales, IsoTis Orthobiologics

    Over galgenhumor gesproken!

    Groet,

    hadikmaar
    ja er zal wel lekker gelachen worden om hoe ze die domme nederlanders en zwitsers toch bezeikt hebben met hun move naar nasdaq HA HA HA....

    ik blijf erbij dit was een wel voorbedachte move naar de nasdaq om overgenomen te worden of de shit van fda nu wel of niet gekomen was.

3 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.483
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.207
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.528
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.651
Aedifica 3 901
Aegon 3.258 322.670
AFC Ajax 538 7.086
Affimed NV 2 6.288
ageas 5.844 109.885
Agfa-Gevaert 14 2.048
Ahold 3.538 74.294
Air France - KLM 1.025 35.000
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.334
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.813
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.835 242.761
AMG 971 133.102
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.936
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.731
Arcelor Mittal 2.033 320.583
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.717
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.082
ASML 1.766 106.071
ASR Nederland 21 4.451
ATAI Life Sciences 1 7
Atenor Group 1 470
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.610
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390